Liberty Latin America Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Liberty Latin America Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,724	3,590	3,706	3,867	3,782	4,811	4,809	4,511	4,447	4,442
Cost of revenue		876	877	878	860	1,214	1,211	1,020	989	976
Gross profit		2,714	2,829	2,989	2,922	3,597	3,598	3,491	3,457	3,466
Selling, general and administrative	522	711	768	803
Selling and marketing			167	173	168	229	226	181	190	180
Operating income	315	-163	-23.6	326	86.7	63.8	86.5	518	-76.8	108
Interest expense	314	382	444	499	533	527	557	602	628	656
Other non-operating income	-413	-488	-561	-634	-925	-382	-210	-580	-583	-761
Pre-tax income	-98.1	-651	-585	-309	-838	-318	-123	-62.4	-660	-653
Income tax	306	148	51.1	-100	-29.2	173	84.8	24.4	-0.2	-98.5
Net income to minority interests	28.3	-20.6	-291	-102	-122	-50	-37.1	-13.2	29.7	56.9
Net income	-432	-778	-345	-106	-687	-441	-171	-73.6	-689	-611
EBITDA	903	631	806	1,216	1,005	1,029	997	1,526	892	1,013
EPS, basic	-4.64	-6.11	-2.64	-0.58	-3.51	-1.89	-0.77	-0.35	-3.47	-3.06
EPS, diluted	-4.64	-6.11	-2.64	-0.58	-3.51	-1.89	-0.77	-0.35	-3.47	-3.06
Shares, basic (weighted)	93.1	127	130	184	196	233	223	210	198	200
Shares, diluted (weighted)	93.1	127	130	184	196	233	223	210	198	200

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	553	530	631	1,184	894	957	781	989	654	784
Receivables	532	557	607	585	559	527	603	686	686	654
Other current assets	252	223	333	227	354	323	339	360	480	472
Total current assets	1,509	1,375	1,645	2,055	1,948	2,052	2,079	2,412	2,115	2,246
Property, plant and equipment	3,861	4,169	4,237	4,301	4,751	4,168	4,294	4,206	4,062	3,848
Lease right-of-use assets				151	329	441	551	475	481	470
Goodwill	6,354	5,674	5,133	4,903	4,886	3,948	3,421	3,483	2,981	3,008
Intangible assets	1,235	1,316	1,166	969	859	789	688	542	414	361
Other non-current assets	579	518	703	873	1,157	1,248	1,501	1,359	1,398	1,444
Total assets	14,144	13,617	13,447	14,938	15,076	15,366	13,575	13,595	12,784	12,226
Accounts payable	219	287	297	347	425	398	525	424	442	385
Accrued liabilities			86	88.9	108	101	82.1	79.1	95.8	102
Deferred revenue		143	162	161	195	148	152	167	126	127
Short-term debt	151	257	293	178	160	106	227	582	466	409
Total current liabilities	1,348	1,587	1,609	1,576	1,699	1,515	1,774	2,133	2,060	1,978
Long-term debt	5,897	6,097	6,376	8,188	8,184	7,460	7,654	7,598	7,615	7,870
Lease liabilities				119	270	371	439	483	450	424
Other non-current liabilities	601	698	553	579	1,081	796	793	832	847	821
Total liabilities	8,484	8,926	9,323	10,958	11,736	12,468	11,019	11,285	11,190	11,162
Total debt	6,026	6,354	6,669	8,366	8,344	7,558	7,872	8,174	8,076	8,271
Paid-in capital		4,403	4,494	4,570	4,982	5,075	5,177	5,262	5,316	5,369
Retained earnings	-233	-1,011	-1,367	-1,447	-2,238	-2,694	-2,868	-2,942	-3,631	-4,242
Treasury stock				0	-9.5	-74	-243	-361	-444	-449
Other comprehensive income	-16.7	-64.2	-16.3	-14.8	-126	-89.7	-149	-198	-154	-125
Shareholders' equity	4,180	3,330	3,113	3,110	2,611	2,220	1,919	1,764	1,089	556
Minority interests	1,481	1,361	1,011	870	729	677	638	546	505	508
Total equity	5,660	4,691	4,041	3,858	3,321	2,894	2,557	2,310	1,594	1,064
Total liabilities and equity	14,144	13,617	13,447	14,938	15,076	15,366	13,575	13,595	12,784	12,226

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-404	-799	-636	-208	-809	-491	-208	-86.8	-660	-554
Depreciation and amortization	587	794	830	890	919	965	911	1,008	968	905
Stock-based compensation	15.4	14.2	39.8	57.5	97.5	118	93.5	88.7	73	54.4
Deferred income tax	93.5	-135	-32.9	-34.7	-65.1	87.1	-8.4	-87.4	-129	-239
Change in payables	151	-212	-67	-152	-85.2	-106	-88.3	-130	-319	-172
Cash from operations	468	573	817	918	640	1,016	869	897	756	806
Capital expenditures	-568	-777	-771	-722	-631	-856	-816	-585	-540	-500
Acquisitions	17	-1.3	-226	-161	-1,886	-521	-231	0	-95.4	0
Purchases of investments							-19.4	-24.9	-47.3	-80
Cash from investing	-424	-640	-981	-635	-2,451	-1,269	-1,123	-616	-689	-592
Debt issued	1,521	1,760	1,235	2,967	1,319	1,249	338	1,093	1,706	1,891
Stock issued			0	0	347	0	0
Share buybacks			0	0	-9.5	-63	-170	-118	-82.9	0
Cash from financing	259	52.9	256	1,540	271	427	-29.2	-62.4	-386	-43.6
Exchange rate effect	3.7	1.7	-18.6	-7.7	-4.9	-12.5	-2.3	-7.9	-10.9	-40.3
Net change in cash	278	-12.6	73.8	1,815	-1,545	162	-285	211	-330	130
Free cash flow	-100	-204	45.4	197	9	160	52.5	312	216	306
Interest paid	305	393	418	445	484	463	506	521	619	600
Income taxes paid	131	111	146	130	81.6	44.3	116	79.8	145	159

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $8.49 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	78.1%	Gross profit / revenue.
Operating margin	14.3%	Operating income / revenue.
EBITDA margin	34.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	1.6%	Pre-tax income / revenue.
Net margin	-2.2%	Net income / revenue.
FCF margin	9.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.2%	Cash from operations / revenue.
Effective tax rate	156.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	-18.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.8%	Net income / average total assets.
Return on invested capital (ROIC)	6.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	10.9%	Capital expenditures / revenue.
D&A / revenue	20.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	7.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	4.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	13.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	0.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	0.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	6.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-2.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	4.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	41.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	79.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	102.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-49.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-33.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-26.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-4.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.19x	Current assets / current liabilities.
Quick ratio	0.73x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.37x	(Cash + short-term investments) / current liabilities.
Debt / equity	16.0x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	69.0%	Total debt / total assets.
Liabilities / assets	91.9%	Total liabilities / total assets.
Net debt	$7.73B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.01x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.96x	Operating income / interest expense.
Working capital	$355.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	27.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.87B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.36x	Revenue / average total assets.
Fixed asset turnover	1.18x	Revenue / average property, plant and equipment.
Receivables turnover	6.61x	Revenue / average receivables.
Days sales outstanding	55 days	365 x average receivables / revenue.
Days payables	120 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	53.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.49	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$22.17	Revenue / diluted weighted shares.
FCF per share	$2.06	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.47	Cash from operations / diluted weighted shares.
Book value per share	$2.63	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$14.25	Tangible book value / shares outstanding.
Cash per share	$3.55	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	6.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.66B	Share price x shares outstanding.
Enterprise value	$9.39B	Market cap + total debt - cash - short-term investments.
P/S	0.37x	Market cap / revenue.
P/B	3.15x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	4.01x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	1.85x	Market cap / cash from operations, when positive.
EV/Sales	2.11x	Enterprise value / revenue.
EV/EBIT	14.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.09x	Enterprise value / EBITDA, when both are positive.
EV/FCF	22.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	25.0%	Free cash flow / market cap.
Earnings yield	-5.9%	Net income / market cap (the inverse of P/E).
Shareholder yield	1.6%	(Dividends paid + share buybacks) / market cap.

What was Liberty Latin America Ltd.'s revenue in fiscal 2025?

Liberty Latin America Ltd. reported revenue of $4.44B for fiscal 2025, 0.1% lower than the year before.

Was Liberty Latin America Ltd. profitable in fiscal 2025?

No. It reported a net loss of $611.2M.

How much free cash flow did Liberty Latin America Ltd. generate in fiscal 2025?

Cash from operations of $805.9M minus capital expenditures of $500.0M left free cash flow of $305.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Liberty Latin America Ltd.